The risk of developing non-arteritic anterior ischemic optic neuropathy is four times higher for diabetics on semaglutide and seven times higher for people taking the drug to lose weight ...

Semaglutide is linked with a rare form of vision loss called non-arteritic anterior ischemic optic neuropathy (NAION). That’s ...

Patients who took the frequently prescribed diabetes and weight-loss drugs Ozempic and Wegovy faced a greater risk of a ...

Increased risk for NAION seen among participants with T2D, overweight/obesity receiving semaglutide vs non-GLP1-RA meds. HealthDay News — Semaglutide is associated with nonarteritic anterior ...

About The Study: The findings of this study suggest an association between semaglutide, a glucagon-like peptide 1 receptor agonist, and nonarteritic anterior ischemic optic neuropathy. As this was ...

By Tarun Sai Lomte A recent study published in the journal JAMA Ophthalmology evaluated associations between semaglutide and ...

New research led by the Massachusetts Eye and Ear Hospital (Mass Eye and Ear) found that semaglutide use was associated with nonarteritic anterior ischemic optic neuropathy (NAION), or ‘eye ...

Over a mean follow-up of nearly 3 years, patients with diabetes on semaglutide had more than a fourfold higher risk for developing nonarteritic anterior ischemic optic neuropathy (NAION ...

as was shown in the ONTT for optic neuritis. Unfortunately, there are many limitations to our study. The major limitation is the retrospective nature of this study which does not allow deducing ...

including nonarteritic anterior ischemic optic neuropathy, neuromyelitis optica, inflammatory optic neuropathies (sarcoid, lupus and giant cell arteritis), infectious optic neuropathies (Lyme ...

What is NAION and how common is it? Nonarteritic anterior ischemic optic neuropathy, or NAION, is a rare condition that afflicts 2 to 10 out of 100,000 people. Like a brain stroke, the condition ...